MFDS — authorised 21 May 2002
- Marketing authorisation holder: UNITED THERAP
- Status: likely_approved
🇰🇷 Remodulin in South Korea
MFDS authorised Remodulin on 21 May 2002
Marketing authorisation
Remodulin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Remodulin approved in South Korea?
Yes. MFDS authorised it on 21 May 2002.
Who is the marketing authorisation holder for Remodulin in South Korea?
UNITED THERAP holds the South Korean marketing authorisation.